Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments

LuminX Biotech was invited by a well-known American social media PRNewswire for a text interview with the title of “Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments.” Mainly mentioned about most breakthrough therapy designations are granted to cell therapies. These therapies face great challenges in pre-market certification, owing to the difficulty of pre-clinical PK/PD data collection. LuminX provides cell GPS positioning in vivo, for researchers and cell therapy companies, our tech will be a game-changer as it drastically cuts down the time and money otherwise needed for research and development.